Author:
Zang R Y,Harter P,Chi D S,Sehouli J,Jiang R,Tropé C G,Ayhan A,Cormio G,Xing Y,Wollschlaeger K M,Braicu E I,Rabbitt C A,Oksefjell H,Tian W J,Fotopoulou C,Pfisterer J,du Bois A,Berek J S
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Alberts DS, Liu PY, Wilczynski SP, Clouser MC, Lopez AM, Michelin DP, Lanzotti VJ, Markman M (2008) Randomized trial of pegylated liposomal doxorubicin (PLD) plus carboplatin versus carboplatin in platinum-sensitive (PS) patients with recurrent epithelial ovarian or peritoneal carcinoma after failure of initial platinum-based chemotherapy (Southwest Oncology Group Protocol S0200). Gynecol Oncol 108: 90–94
2. Berek JS, Hacker NF, Lagasse LD, Nieberg RK, Elashoff RM (1983) Survival of patients following secondary cytoreductive surgery in ovarian cancer. Obstet Gynecol 61: 189–193
3. Bristow RE, Puri I, Chi DS (2009) Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis. Gynecol Oncol 112: 265–274
4. Chi DS, McCaughty K, Diaz JP, Chi DS, McCaughty K, Diaz JP, Huh J, Schwabenbauer S, Hummer AJ, Venkatraman ES, Aghajanian C, Sonoda Y, Abu-Rustum NR, Barakat RR (2006) Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma. Cancer 106: 1933–1939
5. Chmura Kraemer H (1992) Evaluating Medical Tests: Objective and Quantitative Guidelines. SAGE: Newbury Park, CA
Cited by
104 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献